Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma

Journal of the American College of Surgeons

Volumn 215, Issue 3, 2012, Pages 361-369

  Martin II, Robert C G ^a   McFarland, Kelli ^b   Ellis, Susan ^a   Velanovich, Vic ^b  

^a University of Louisville School of Medicine   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE;

ABLATION THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; ELECTROPORATION; FEMALE; FOLLOW UP; HUMAN; IMAGING SYSTEM; INTRAOPERATIVE PERIOD; IRREVERSIBLE ELECTROPORATION; MALE; MORBIDITY; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ABLATION TECHNIQUES; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; ELECTROPORATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84865201996     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2012.05.021     Document Type: Article

References (64)

1. A. Jemal, F. Bray, M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. D.K. Espey, X.C. Wu, J. Swan Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives Cancer 110 2007 2119 2152 (Pubitemid 350100734)
3. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database Cancer 110 2007 738 744 (Pubitemid 47257648)
4. SEER Program NPN-, Bethesda, MD Cancer of the Pancreas. SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 19882001. Patient Tumor Characteristics. National Cancer Institute http://seer.cancer.gov/ publications/survival/surv.pancrease.pdf
5. S.B. Edge, D.R. Byrd, C.C. Compton, AJCC Cancer Staging Manual 7th ed. 2009 Springer-Verlag New York 117 126
6. M.P. Callery, K.J. Chang, E.K. Fishman Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 2009 1727 1733
7. G.R. Varadhachary, E.P. Tamm, J.L. Abbruzzese Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 2006 1035 1046 (Pubitemid 44337962)
8. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 1988 751 755
9. Gastrointestinal Tumor Study Group Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma Cancer 56 1985 2563 2568
10. F. Huguet, T. Andre, P. Hammel Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies J Clin Oncol: official journal of the American Society of Clinical Oncology 25 2007 326 331 (Pubitemid 350003022)
11. B. Chauffert, F. Mornex, F. Bonnetain Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer Definitive results of the 200001 FFCD/SFRO study Ann Oncol: official journal of the European Society for Medical Oncology/ESMO 19 2008 1592 1599
12. R. Wilkowski, S. Boeck, S. Ostermaier Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancera multi-centre randomised phase II study Br J Cancer 101 2009 1853 1859
13. M.G. Haddock, R. Swaminathan, N.R. Foster Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942 J Clin Oncol: official journal of the American Society of Clinical Oncology 25 2007 2567 2572 (Pubitemid 47041230)
14. M.S. Talamonti, W. Small Jr, M.F. Mulcahy A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma Ann Surg Oncol 13 2006 150 158 (Pubitemid 43157408)
15. B. Al-Sakere, F. Andre, C. Bernat Tumor ablation with irreversible electroporation PloS one 2 2007 e1135
16. J.F. Edd, L. Horowitz, R.V. Davalos In vivo results of a new focal tissue ablation technique: irreversible electroporation IEEE Transactions on Bio-medical Engineering 53 2006 1409 1415 (Pubitemid 44172315)
17. R.V. Davalos, I.L. Mir, B. Rubinsky Tissue ablation with irreversible electroporation Ann Biomed Eng 33 2005 223 231 (Pubitemid 40496051)
18. R.V. Davalos, D.M. Otten, L.M. Mir, B. Rubinsky Electrical impedance tomography for imaging tissue electroporation IEEE Transactions on Bio-medical Engineering 51 2004 761 767 (Pubitemid 38525709)
19. R. Davalos, B. Rubinsky Electrical impedance tomography of cell viability in tissue with application to cryosurgery J Biomed Eng 126 2004 305 309 (Pubitemid 38655935)
20. R.V. Davalos, B. Rubinsky, L.M. Mir Theoretical analysis of the thermal effects during in vivo tissue electroporation Bioelectrochemistry 61 2003 99 107 (Pubitemid 37468203)
21. M. Bower, L. Sherwood, Y. Li, R. Martin Irreversible electroporation of the pancreas: definitive local therapy without systemic effects J Surg Oncol 104 2011 22 28
22. R.C. Martin, C.R. Scoggins, V. Egnatashvili Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes Arch Surg 144 2009 154 159
23. M.A. Makary, E.K. Fishman, J.L. Cameron Resection of the celiac axis for invasive pancreatic cancer J Gastrointest Surg 9 2005 503 507 (Pubitemid 40431728)
24. R.C. Martin, V. Augenstein, N.P. Reuter Simultaneous versus staged resection for synchronous colorectal cancer liver metastases J Am Coll Surg 208 2009 842 850
25. N. Merchant, G.D. Ayers, C.M. Schmidt Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? J Am Coll Surg 208 5 2009 829 838
26. K.D. Lillemoe, J.L. Cameron, J.M. Hardacre Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial Ann Surg 230 1999 322 328
27. M.M. Austine Palliation of advanced gastrointestinal malignancies using minimally invasive strategies P, T Progress in Palliative Care 17 2009 250 260
28. A. Raben, B. Mychalczak, M.F. Brennan Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy Int J Rad Oncol Biol Phys 35 1996 351 356
29. P.J. Kneuertz, S.C. Cunningham, J.L. Cameron Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience J Gastrointest Surg 15 2011 1917 1927
30. P.J. Kneuertz, D.P. Cosgrove, A.M. Cameron Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation J Gastrointest 15 11 2011 1917 1927
31. C.G. Moertel, S. Frytak, R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710 (Pubitemid 11022870)
32. R. Whittington, L. Solin, M. Mohiuddin Multimodality therapy of localized unresectable pancreatic adenocarcinoma Cancer 54 1984 1991 1998 (Pubitemid 14020634)
33. J.E. Tepper, D. Noyes, J.M. Krall Intraoperative radiation therapy of pancreatic carcinoma: a report of RTOG-8505 Radiation Therapy Oncology Group Int J Rad Oncol Biol Phys 21 1991 1145 1149
34. K.D. Lillemoe, J.L. Cameron, J.M. Hardacre Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial Ann Surg 230 1999 322 328
35. M. Yamamuro, K. Kusaka, M. Kato, M. Takahashi Celiac plexus block in cancer pain management Tohoku J Exp Med 192 2000 1 18
36. A. Pietrabissa, F. Vistoli, A. Carobbi Thoracoscopic splanchnicectomy for pain relief in unresectable pancreatic cancer Arch Surg 135 2000 332 335 (Pubitemid 30154576)
37. F. Gress, C. Schmitt, S. Sherman Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience Am J Gastroenterol 96 2001 409 416
38. A.C. Koong, E. Christofferson, Q.T. Le Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer Int J Rad Oncol Biol Phys 63 2005 320 323 (Pubitemid 41317146)
39. D.T. Chang, D. Schellenberg, J. Shen Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
40. M.S. Didolkar, C.W. Coleman, M.J. Brenner Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients J Gastrointest Surg 14 2010 1547 1559
41. C.H. Crane, G.R. Varadhachary, J.S. Yordy Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression J Clin Oncol 29 2011 3037 3043
42. J.C. Weaver, T.E. Vaughan, Y. Chizmadzhev Theory of skin electroporation: implications of straight-through aqueous pathway segments that connect adjacent corneocytes J Invest Dermatol 3 1998 143 147 (Pubitemid 29135210)
43. H. Stopper, U. Zimmermann, E. Wecker High yields of DNA-transfer into mouse L-cells by electropermeabilization Zeitschrift fur Naturforschung Section C: Biosciences 40 1985 929 932
44. E. Neumann, M. Schaefer-Ridder, Y. Wang, P.H. Hofschneider Gene transfer into mouse lyoma cells by electroporation in high electric fields EMBO journal 1 1982 841 845
45. J. Teissie [New applications of electricity in clinical practice] Presse medicale 22 1993 1142 1147 (Pubitemid 23248616)
46. J. Teissie, B. Gabriel, M. Prats Lateral communication by fast proton conduction: a model membrane study Trends Biochem Sci 18 1993 243 246 (Pubitemid 23186852)
47. J. Teissie, M. Golzio, M.P. Rols Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge Biochimica et biophysica acta 1724 2005 270 280 (Pubitemid 41080035)
48. J.C. Weaver, T.E. Vaughan, Y. Chizmadzhev Theory of electrical creation of aqueous pathways across skin transport barriers Advanced Drug Delivery Rev 35 1999 21 39 (Pubitemid 29046384)
49. I.A. Chang, U.D. Nguyen Thermal modeling of lesion growth with radiofrequency ablation devices Biomed Eng online 3 2004 27
50. J. Lavee, G. Onik, P. Mikus, B. Rubinsky A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation Heart Surg Forum 10 2007 E162 E167
51. K.P. Charpentier, F. Wolf, L. Noble Irreversible electroporation of the liver and liver hilum in swine HPB 13 2011 168 173
52. K.P. Charpentier, F. Wolf, L. Noble Irreversible electroporation of the pancreas in swine: a pilot study HPB 12 2010 348 351
53. M.D. Chandrasegaram, G.D. Eslick, C.O. Mansfield Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction Surg Endosc 26 2012 323 329
54. P.J. Allen, J. Chou, M. Janakos Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma Ann Surg Oncol 18 2011 636 641
55. M.K. Melnik, C.P. Webb, P.J. Richardson Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer Mol Cancer Ther 9 2010 2423 2429
56. J.M. Wyse, M. Carone, S.C. Paquin Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer J Clin Oncol 29 2011 3541 3546
57. J.P. Arnoletti, A. Frolov, M. Eloubeidi A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer Cancer Chemother Pharmacol 67 2011 891 897
58. C. Milandri, R. Polico, D. Garcea GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer Hepato-gastroenterology 58 2011 599 603
59. K. Shibuya, N. Oya, T. Fujii Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer Am J Clin Oncol 34 2011 115 119
60. L. Oberic, F. Viret, C. Baey Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival Rad Oncol 6 2011 124
61. H.J. Mamon, D. Niedzwiecki, D. Hollis A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma: cancer and Leukemia Group B (CALGB) 80003 Cancer 117 2011 2620 2628
62. S. Maluta, M. Schaffer, F. Pioli Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer: an open-label comparative cohort trial Strahlenther Onkol 187 2011 619 625
63. T. Brunner [Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis] Strahlenther Onkol 188 2012 366 367
64. P.J. Loehrer Sr, Y. Feng, H. Cardenes Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial J Clin Oncol 29 2011 4105 4112